The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization

FASEB Journal

Volumn 25, Issue 11, 2011, Pages 3906-3914

  Veschini, Lorenzo ^a   Crippa, Luca ^a,b   Dondossola, Eleonora ^a,b   Doglioni, Claudio ^a   Corti, Angelo ^a,b   Ferrero, Elisabetta ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Cell junctions; Stalk cells; Tip cells

Indexed keywords

CHROMOGRANIN A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5A8; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASOSTATIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST ADENOCARCINOMA; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GAP JUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SUPERNATANT; TUMOR GROWTH; TUMOR VASCULARIZATION; WILD TYPE;

ADENOCARCINOMA; ANIMALS; ANOXIA; CELL LINE, TUMOR; CHROMOGRANIN A; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PHENOTYPE;

EID: 80355148473     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-182410     Document Type: Article

References (33)

1. Semenza, G. L. (2003) Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54, 17-28
2. Moserle, L., Amadori, A., and Indraccolo, S. (2009) The angiogenic switch: implications in the regulation of tumor dormancy. Curr. Mol. Med. 9, 935-941
3. Subarsky, P., and Hill, R. P. (2003) The hypoxic tumour microenvironment and metastatic progression. Clin. Exp. Metastasis 20, 237-250 (Pubitemid 36513228)
4. Fukumura, D., and Jain, R. K. (2007) Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell. Biochem. 101, 937-949 (Pubitemid 47040874)
5. Veschini, L., Belloni, D., Foglieni, C., Cangi, M. G., Ferrarini, M., Caligaris-Cappio, F., and Ferrero, E. (2007) Hypoxia-inducible transcription factor-1α determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood 109, 2565-2570 (Pubitemid 46425903)
6. Calvani, M., Rapisarda, A., Uranchimeg, B., Shoemaker, R. H., and Melillo, G. (2006) Hypoxic induction of an HIF-1α-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107, 2705-2712
7. Belloni, D., Veschini, L., Foglieni, C., Dell'Antonio, G., Caligaris- Cappio, F., Ferrarini, M., and Ferrero, E. (2010) Bortezomib induces autophagic death in proliferating human endothelial cells. Exp. Cell Res. 316, 1010-1018
8. Aird, W. C. (2008) Endothelium in health and disease. Pharmacol. Rep. 60, 139-143
9. De Smet, F., Segura, I., De Bock, K., Hohensinner, P. J., and Carmeliet, P. (2009) Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler. Thromb. Vasc. Biol. 29, 639-649
10. Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y. M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., De Smet, F., Vinckier, S., Aragones, J., Debackere, K., Luttun, A., Wyns, S., Jordan, B., Pisacane, A., Gallez, B., Lampugnani, M. G., Dejana, E., Simons, M., Ratcliffe, P., Maxwell, P., and Carmeliet, P. (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851
11. Fischer, C., Mazzone, M., Jonckx, B., and Carmeliet, P. (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for antiangiogenic therapy? Nat. Rev. Cancer 8, 942-956
12. Carmeliet, P., De Smet, F., Loges, S., and Mazzone, M. (2009) Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat. Rev. Clin. Oncol. 6, 315-326
13. Jain, R. K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62
14. Helle, K. B. (2010) Regulatory peptides from chromogranin A and secretogranin II. Cell. Mol. Neurobiol. 30, 1145-1146
15. Colombo, B., Curnis, F., Foglieni, C., Monno, A., Arrigoni, G., and Corti, A. (2002) Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. Cancer Res. 62, 941-946 (Pubitemid 34126976)
16. Corti A (2010) Chromogranin A and the tumor microenvironment. Cell. Mol. Neurobiol. 30, 1163-1179
17. Di Comite, G., and Morganti, A. (2011) Chromogranin A: a novel factor acting at the cross road between the neuroendocrine and the cardiovascular systems. J. Hypertens. 29, 409-414
18. Bhavani, S. S., Parshuram, J. S., and Mahapatra, N. R. (2010) Chromogranin A: a novel susceptibility gene for essential hypertension. Cell. Mol. Life Sci. 67, 861-874
19. Ferrero, E., Scabini, S., Magni, E., Foglieni, C., Belloni, D., Colombo, B., Curnis, F., Villa, A., Ferrero, M. E., and Corti, A. (2004) Chromogranin A protects vessels against tumor necrosis factor α-induced vascular leakage. FASEB J. 18, 554-556
20. Belloni, D., Scabini, S., Foglieni, C., Veschini, L., Giazzon, A., Colombo, B., Fulgenzi, A., Helle, K. B., Ferrero, M. E., Corti, A., and Ferrero, E. (2007) The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration. FASEB J. 21, 3052-3062 (Pubitemid 47565526)
21. Ramella, R., Boero, O., Alloatti, G., Angelone, T., Levi, R., and Gallo, M. P. (2010) Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism. J. Cell. Biochem. 110, 70-79
22. Corti, A., Sanchez, L. P., Gasparri, A., Curnis, F., Longhi, R., Brandazza, A., Siccardi, A. G., and Sidoli, A. (1997) Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) - evidence of dimer-monomer equilibria. Eur. J. Biochem. 248, 692-699 (Pubitemid 27400022)
23. Langheim, S., Dreas, L., Veschini, L., Maisano, F., Foglieni, C., Ferrarello, S., Sinagra, G., Zingone, B., Alfieri, O., Ferrero, E., Maseri, A., and Ruotolo, G. (2010) Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am. J. Physiol. Heart Circ. Physiol. 298, H746-H753
24. Millan, J., Cain, R. J., Reglero-Real, N., Bigarella, C., Marcos- Ramiro, B., Fernandez-Martin, L., Correas, I., and Ridley, A. J. (2010) Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol. 8, 11
25. De Bock, K., De Smet, F., Leite De Oliveira, R., Anthonis, K., and Carmeliet, P. (2009) Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells. J. Mol. Med. 87, 561-569
26. Kerbel, R. S. (2008) Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049
27. Fukumura, D., and Jain, R. K. (2007) Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res. 74, 72-84 (Pubitemid 350051025)
28. Bautch, V. L. (2009) Endothelial cells form a phalanx to block tumor metastasis. Cell 136, 810-812
29. Cowan, C. E., Kohler, E. E., Dugan, T. A., Mirza, M. K., Malik, A. B., and Wary, K. K. (2010) Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ. Res. 107, 959-966
30. Pages, G., and Pouyssegur, J. (2005) Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc. Res. 65, 564-573 (Pubitemid 40138977)
31. Semenza, G. L. (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625-634
32. Gao, J., Sun, L., Huo, L., Liu, M., Li, D., and Zhou, J. (2010) CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Blood 115, 4130-4137
33. Theurl, M., Schgoer, W., Albrecht, K., Jeschke, J., Egger, M., Beer, A. G., Vasiljevic, D., Rong, S., Wolf, A. M., Bahlmann, F. H., Patsch, J. R., Wolf, D., Schratzberger, P., Mahata, S. K., and Kirchmair, R. (2010) The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism Circ. Res. 107, 1326-1335